The oral potassium-competitive acid blocker (PCAB) vonoprazan was noninferior and superior to the proton pump inhibitor (PPI) lansoprazole for erosive esophagitis, according to results of the phase 3 ...
Please provide your email address to receive an email when new articles are posted on . “The ethos of the new GERD guidelines is to synthesize the highest quality, yet still practical, recommendations ...
Tegoprazan demonstrated statistically superior maintenance of healing in all patients across all grades (LA Grades A–D) of erosive esophagitis (EE) and in the most severe patients (LA Grades C/D) ...
The investigational monoclonal antibody cendakimab significantly improved symptoms and reduced esophageal eosinophils in patients with eosinophilic esophagitis at 24 weeks, a randomized phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback